Use access key #2 to skip to page content.
$3.51 0.25 (7.67%)
7/8/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar psi21286 (91.40) Submitted: 4/25/08 3:51 PM : Outperform Start Price: $8.05 ACAD Score: -45.57

Who doesn't love pharmaceutical companies? They charge a fortune for their drugs and make huge profits. Risky if a drug loses FDA approval, but great if they get a cutting edge drug on th market.

Report this Post Replies: 0 | Reply

Featured Broker Partners